Question to the Cabinet Office:

To ask His Majesty's Government whether deceased people impacted by infected blood are entitled to the Level 2B award, as set out in their response to the consultation on changes to the infected blood compensation scheme, published on 14 April.

Yes, deceased infected people will be eligible. As set out in the Government’s response to the consultation, the Government will introduce a Level 2B banding to recognise the harms caused by treatment with interferon. Anyone who can evidence treatment with interferon (with or without other drugs, such as ribavirin) will automatically qualify for Level 2B, without having to prove the duration of their treatment, side effects, financial loss or care needs. This includes the estates of deceased infected people.